Management of Non-Specific Intraventricular Conduction Delay (NSIVCD)

Risk Stratification by QRS Duration

The American College of Cardiology recommends that if QRS ≥140 ms, an echocardiogram should be obtained to exclude structural heart disease, as this threshold is considered abnormal and warrants further evaluation regardless of QRS morphology 1, 2, 3
The American College of Cardiology suggests that epidemiological data demonstrate an increased risk of cardiovascular death in the general population with NSIVCD, particularly when associated with cardiomyopathy, with a recommendation to obtain a transthoracic echocardiogram to evaluate for myocardial disease, left ventricular systolic dysfunction, cardiomyopathy, valvular disease, and infiltrative processes 1, 2, 4, 5

The American College of Cardiology indicates that ambulatory electrocardiographic monitoring is indicated to establish symptom-rhythm correlation and document suspected higher-degree atrioventricular block in patients with symptoms suggesting intermittent bradycardia, such as lightheadedness, presyncope, or syncope 4, 5, 6
The American College of Cardiology recommends that an electrophysiologic study is reasonable to assess for intermittent high-grade conduction block, particularly if HV interval ≥70 ms or frank infranodal block is demonstrated, in patients with persistent symptoms and negative ambulatory monitoring 4, 5

The American College of Cardiology suggests that advanced imaging with cardiac MRI, CT, or nuclear studies is reasonable to detect subclinical cardiomyopathy, sarcoidosis, myocarditis, or connective tissue disease if the echocardiogram is normal but clinical suspicion remains high 4, 6

The American College of Cardiology recommends that athletes with profound NSIVCD (QRS ≥140 ms) should undergo echocardiogram, as the physiology likely includes neurally mediated conduction fiber slowing and increased myocardial mass, and additional testing may be indicated based on findings or clinical suspicion 1, 2, 3

The American College of Cardiology indicates that symptoms of heart failure, family history of cardiomyopathy or sudden cardiac death, syncope or presyncope, known conditions predisposing to structural heart disease, and age ≥30 years with risk factors for coronary artery disease increase suspicion for underlying pathology and warrant echocardiography even with QRS <140 ms 1, 4, 3, 5, 6

NSIVCD is defined in adults as a QRS duration > 110 ms when the QRS morphology does not meet the specific criteria for complete right‑ or left‑bundle‑branch block. 7
In children, the diagnostic thresholds differ: QRS ≥ 90 ms for ages < 4 years and QRS ≥ 100 ms for ages 4–16 years. 8

QRS duration should be measured using the global interval (earliest onset to latest offset across all leads) rather than a single‑lead measurement to avoid under‑estimation. 8

Population‑based studies show that individuals with NSIVCD have a higher risk of cardiovascular death compared with those without the finding. 9
NSIVCD is frequently associated with structural heart disease, most commonly various forms of cardiomyopathy (ischemic, hypertensive, dilated, or infiltrative). 9
The underlying pathophysiology is thought to involve a combination of neurally mediated slowing of conduction fibers and increased myocardial mass. 9

Profound NSIVCD (QRS ≥ 140 ms): This threshold is considered abnormal irrespective of QRS morphology and mandates a transthoracic echocardiogram in all patients, including athletes. 9
Mild‑to‑moderate NSIVCD (QRS 110–139 ms): Echocardiography is recommended when the patient is ≥ 30 years old and has coronary artery disease risk factors. 9

Transthoracic echocardiography is the primary imaging modality to assess for structural heart disease, including cardiomyopathy and valvular pathology. 9
Exercise or pharmacologic stress testing is advised for adults ≥ 30 years with coronary risk factors to detect inducible myocardial ischemia. 9
Cardiac magnetic resonance imaging is reasonable when the echocardiogram is normal but clinical suspicion for subclinical cardiomyopathy, infiltrative disease, or myocarditis remains high. 9

A mild prolongation of the QT interval accompanying NSIVCD may reflect coexisting left ventricular hypertrophy. 10

Athletes who exhibit profound NSIVCD (QRS ≥ 140 ms) require echocardiographic evaluation regardless of symptom status. 9
The electrophysiologic phenotype in athletes is likely related to neurally mediated conduction slowing combined with increased myocardial mass. 9